Displaying drugs 6851 - 6875 of 7378 in total
(6R)-Folinic acid
Experimental
Insulin-like growth factor II
The insulin-like growth factor II is a well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. This factor presents effects related to growth regulation, insulin-like and mitogenic activities. To perform its biological activities, this growth factor can present some dependence to somatotropin. It...
Experimental
Fazirsiran
Investigational
Relmacabtagene autoleucel
Investigational
Edobacomab
Investigational
Combretastatin A4
Experimental
Investigational
Morin
Experimental
DRF-1042
Investigational
GTA002
Investigational
ETX101
ETX101 is a non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene.
Investigational
Suzetrigine
Suzetrigine is under investigation in clinical trial NCT05558410 (Evaluation of Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty).
Investigational
Cinpanemab
Cinpanemab is under investigation in clinical trial NCT03318523 (Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease).
Investigational
NB-124 sulfate
Investigational
Zinc mesoporphyrin
Investigational
Displaying drugs 6851 - 6875 of 7378 in total